Tuesday, March 17, 2026

Why BAT’s Platinum Certification from AWS Sets a New Standard for Water Resource Management

BAT Korea's Sacheon factory earns Platinum certification from AWS for excellence in water resource management and community collaboration.

OpenAI and Kakao Reveal Strategic Alliance to Drive AI Innovation in South Korea

OpenAI partners with Kakao to enhance AI accessibility, leveraging Kakao's platforms for user-friendly services and joint product development.

When Pyongyang’s Top Diplomat Vanishes From the Front Row

North Korean officials commemorated Kim Jong Il's birthday, but key leaders were absent, hinting at significant policy discussions ahead.

Tag: Oncology

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.